Research Article

Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience

Volume: 2 Number: 3 December 7, 2019

Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience

Abstract

Objective: The aim of this study is to evaluate the diagnosis and treatment results of patients who underwent endoscopic surgery in our clinic due to malignant paranasal sinus tumors. Material and Methods: Between January 2009 and December 2018, the files of patients with malignant paranasal sinus tumors, who were treated with endoscopic surgery only, without combining it with open surgery, were evaluated retrospectively. Demographic data, histopathological diagnosis, surgical characteristics, postoperative complications, and treatment results were determined. Results: A total of 15 patients, consisting of 7 males and 8 females, aged 17–84 years (average of 50.13) were included in the study. The most common symptom was nasal obstruction, followed by epistaxis. Histopathologic diagnosis was adenocarcinoma in 4 patients; olfactory neuroblastoma in 3 patients; hemangiopericytoma in 2 patients; and squamous cell carcinoma, malignant melanoma, adenoid cystic carcinoma, sinonasal differencing carcinoma, and small cell carcinoma in the remaining patients. The diagnosis of malignant mesenchymal tumor and extramedullary plasmacytoma was determined as two separate histopathologic diagnoses in 1 patient. The average follow-up period was determined as 33.3 months. Ten patients received postoperative adjuvant therapy, and 4 patients developed local recurrence. Conclusion: In patients with malignant paranasal sinus tumors, if negative surgical margins could be achieved with endoscopic surgery, endoscopic techniques have become more preferred today due to low morbidity rates. Successful oncologic results can be obtained with adjuvant therapies, even if there is a positive surgical margin with endoscopic surgeries.

Keywords

References

  1. Dutta R, Dubal PM, Svider PF, Liu JK, Baredes S, Eloy JA. Sinonasal malignancies: A population-based analysis of site-specific incidence and survival. Laryngoscope 2015; 125: 2491-7.
  2. Hörmann K. Tumors of the nasal cavity and the paranasal sinuses: an update of current opinions and advances in etiology, diagnostic and therapy. Otolaryngol Pol 2000; 54: 251-8.
  3. Maghami E, Kraus DH. Cancer of the nasal cavity and paranasal sinuses. Expert Rev Anticancer Ther 2004; 4: 411-24.
  4. Gomes P, Gomes A, Salvador P, Lombo C, Caselhos S, Fonseca R. Clinical assessment, diagnosis and management of patients with unilateral sinonasal disease. Acta Otorrinolaringol Esp 2019; pii: S0001-6519(19)30034-2.
  5. Tajudeen BA, Kennedy DW. Thirty years of endoscopic sinus surgery: What have we learned? World J Otorhinolaryngol Head Neck Surg 2017; 3: 115-121.
  6. Govindaraj S, Adappa ND, Kennedy DW. Endoscopic sinus surgery: evolution and technical innovations. J Laryngol Otol 2010; 124: 242-50.
  7. Harvey RJ, Gallagher RM, Sacks R. Extended endoscopic techniques for sinonasal resections. Otolaryngol Clin North Am 2010; 43: 613-38.
  8. Nicolai P, Battaglia P, Bignami M, Bolzoni Villaret A, Delù G, Khrais T, et al. Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience. Am J Rhinol 2008; 22: 308-16.

Details

Primary Language

English

Subjects

Otorhinolaryngology

Journal Section

Research Article

Publication Date

December 7, 2019

Submission Date

October 25, 2019

Acceptance Date

December 2, 2019

Published in Issue

Year 2019 Volume: 2 Number: 3

APA
Yavuz, H. B., Aslıer, M., Demir, U. L., & Kasapoğlu, F. (2019). Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience. European Journal of Rhinology and Allergy, 2(3), 75-78. https://doi.org/10.5152/ejra.2019.230
AMA
1.Yavuz HB, Aslıer M, Demir UL, Kasapoğlu F. Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience. Eur J Rhinol Allergy. 2019;2(3):75-78. doi:10.5152/ejra.2019.230
Chicago
Yavuz, Hüseyin Barkın, Mustafa Aslıer, Uygar Levent Demir, and Fikret Kasapoğlu. 2019. “Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience”. European Journal of Rhinology and Allergy 2 (3): 75-78. https://doi.org/10.5152/ejra.2019.230.
EndNote
Yavuz HB, Aslıer M, Demir UL, Kasapoğlu F (December 1, 2019) Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience. European Journal of Rhinology and Allergy 2 3 75–78.
IEEE
[1]H. B. Yavuz, M. Aslıer, U. L. Demir, and F. Kasapoğlu, “Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience”, Eur J Rhinol Allergy, vol. 2, no. 3, pp. 75–78, Dec. 2019, doi: 10.5152/ejra.2019.230.
ISNAD
Yavuz, Hüseyin Barkın - Aslıer, Mustafa - Demir, Uygar Levent - Kasapoğlu, Fikret. “Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience”. European Journal of Rhinology and Allergy 2/3 (December 1, 2019): 75-78. https://doi.org/10.5152/ejra.2019.230.
JAMA
1.Yavuz HB, Aslıer M, Demir UL, Kasapoğlu F. Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience. Eur J Rhinol Allergy. 2019;2:75–78.
MLA
Yavuz, Hüseyin Barkın, et al. “Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience”. European Journal of Rhinology and Allergy, vol. 2, no. 3, Dec. 2019, pp. 75-78, doi:10.5152/ejra.2019.230.
Vancouver
1.Hüseyin Barkın Yavuz, Mustafa Aslıer, Uygar Levent Demir, Fikret Kasapoğlu. Endoscopic Surgery for Sinonasal Cancer: Uludağ Experience. Eur J Rhinol Allergy. 2019 Dec. 1;2(3):75-8. doi:10.5152/ejra.2019.230

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.